FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q3 2022

Top Holdings311 positions

Checking export access…
Activity:
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

4.7M$1.7B9.1%———
Increased
—

IQVIA HLDGS INC

3.2M$581M3.2%$145.73+24.62%
16 qtrssince 2018-Q4
Decreased
0

THERMO FISHER SCIENTIFIC INC

1.1M$569.1M3.1%$393.62+27.29%
12 qtrssince 2019-Q4
Decreased
0
CHNGCHNGDelisted

CHANGE HEALTHCARE INC

18.1M$496.9M2.7%——
7 qtrssince 2021-Q1
Increased
82

ARAMARK

15.9M$496.8M2.7%$24.80-12.97%
8 qtrssince 2020-Q4
Decreased
0

BOSTON SCIENTIFIC CORP

12.2M$470.6M2.6%$38.68+0.13%
9 qtrssince 2020-Q3
Decreased
0

TransUnion

7.9M$470.4M2.6%$90.56-35.32%
16 qtrssince 2018-Q4
Increased
57

CLARIVATE PLC

40.5M$380.7M2.1%$12.74-27.88%
3 qtrssince 2022-Q1
Increased
78

ELEVANCE HEALTH INC FORMERLY

801,400$364M2.0%$291.80+49.24%
16 qtrssince 2018-Q4
Decreased
0

TWITTER INC

7.8M$340M1.9%——
2 qtrssince 2022-Q2
Increased
52

MICROSOFT CORP

1.4M$335.2M1.8%$146.90+53.43%
16 qtrssince 2018-Q4
Increased
55

CENTENE CORP DEL

4.3M$330.9M1.8%$61.08+27.39%
11 qtrssince 2020-Q1
Decreased
0

ALPHABET INC

3.4M$324.1M1.8%$84.96+12.11%
16 qtrssince 2018-Q4
Increased
79

ACTIVISION BLIZZARD INC

4.2M$309.7M1.7%——
3 qtrssince 2022-Q1
Increased
52
AZNAZN
ADR

ASTRAZENECA PLC

5.6M$306.3M1.7%$114.06-10.36%
5 qtrssince 2021-Q3
Increased
58

EQUIFAX INC

1.8M$306M1.7%$192.36-15.13%
16 qtrssince 2018-Q4
Increased
54

HOWMET AEROSPACE INC

9.8M$304.4M1.7%$28.78+6.16%
10 qtrssince 2020-Q2
Decreased
0

MASTERCARD INCORPORATED

1.1M$303.8M1.7%$342.92-19.06%
7 qtrssince 2021-Q1
Decreased
0

SALESFORCE INC

2.1M$296.4M1.6%$191.79-26.41%
12 qtrssince 2019-Q4
Increased
57

ZENDESK INC

3.9M$296M1.6%——
4 qtrssince 2021-Q4
Increased
79
$18.2B
AUM
311
Positions
Q3 2022
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+8%Q2'21$20.7B-10%Q3'21$18.6B-5%Q4'21$17.7B+2%Q1'22$18.1B-6%Q2'22$17B-4%Q3'22$16.3B
Activity profile
$ moved · Q3'22
New16%Increased39%Decreased30%Exited15%
Composition
Equity vs derivatives
Equity90%Puts10%Calls0%
Holding period
Avg 1.3 years
<1Q4%1-4Q28%1-2Y50%2Y+18%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $18.2B across 311 positions as of Q3 2022. Top holdings: SPY puts (9.1%), IQV (3.2%), TMO (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q3 2022 Summary

Active quarter - 18 new positions, 23 exits, 41 increased. Top move: CHNG (INCREASED, conviction 82). Portfolio: $18.2B across 311 positions.

Top holdings by portfolio weight

Total AUM$16B
IQV3.19%
TMO3.13%
CHNG2.73%
ARMK2.73%
BSX2.58%
TRU2.58%
CLVT2.09%
ELV2.00%
TWTR1.87%
MSFT1.84%
Other1.82%

Portfolio allocation by GICS sector

Sectors11
Healthcare31.52%
Unknown21.76%
Technology14.62%
Financial Services12.19%
Industrials9.40%
Communication Services5.37%
Real Estate2.55%
Basic Materials1.73%
Utilities0.53%
Consumer Cyclical0.25%
Other0.07%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L46
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used